newsfilter
← Latest News
PR Newswire·

FibroBiologics Regains Compliance with Nasdaq Trading Rules

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending...